Literature DB >> 14986160

West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas.

H G Zeller1, I Schuffenecker.   

Abstract

West Nile (WN) virus is a mosquito-transmitted flavivirus. It is widely distributed in Africa, the Middle East, Asia, and southern Europe and was recently introduced to North America. Birds are involved in the cycle of transmission as amplifying hosts. Humans and horses are considered accidental dead-end hosts. WN fever was initially considered a minor arbovirosis, usually inducing a nonsymptomatic or a mild flu-like illness in humans, but some cases of encephalitis associated with fatalities were reported in Israel in the 1950s. After two silent decades, several human and equine outbreaks of fatal encephalitis occurred from 1996 to 2000 in Romania, Morocco, Tunisia, Italy, Russia, Israel, and France. In Romania, a few cases of WN encephalitis in humans are noticed every year, and in France, recent WN infections have been detected in monitored sentinel birds in 2001 and 2002. Phylogenetic studies have shown two main lineages of WN strains. Strains from lineage I are present in Africa, India, and Australia and are responsible for the outbreaks in Europe and in the Mediterranean basin, and strains from lineage II have been reported only in sub-Saharan Africa. In 1998, a virulent WN strain from lineage I was identified in dying migrating storks and domestic geese showing clinical symptoms of encephalitis and paralysis in Israel. A nearly identical WN strain suddenly emerged in New York in 1999, killing thousands of native birds and causing fatal cases in humans. The virus is now well established in the New World, and it disseminates rapidly. New modes of transmission through blood donations, organ transplants, and the intrauterine route have been reported. In Europe, an enhanced surveillance of WN infection in humans, horses, birds, and vectors may reveal the presence of the virus in different locations. Nevertheless, outbreaks of WN virus remain unpredictable. Further coordinated studies are needed for a better understanding of the ecology and the pathogenicity of the WN virus.

Entities:  

Mesh:

Year:  2004        PMID: 14986160     DOI: 10.1007/s10096-003-1085-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   5.103


  73 in total

Review 1.  Variations in biological features of West Nile viruses.

Authors:  V Deubel; L Fiette; P Gounon; M T Drouet; H Khun; M Huerre; C Banet; M Malkinson; P Desprès
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

2.  [Epidemiology of the West Nile virus: study of a focus in Camargue. IV. Meningo-encephalomyelitis of the horse].

Authors:  L Joubert; J Oudar; C Hannoun; D Beytout; B Corniou; J C Guillon; R Panthier
Journal:  Ann Inst Pasteur (Paris)       Date:  1970-02

3.  Neurological features of West Nile virus infection during the 2000 outbreak in a regional hospital in Israel.

Authors:  C Klein; I Kimiagar; L Pollak; R Gandelman-Marton; A Itzhaki; R Milo; J M Rabey
Journal:  J Neurol Sci       Date:  2002-08-15       Impact factor: 3.181

4.  West Nile outbreak in horses in southern France, 2000: the return after 35 years.

Authors:  B Murgue; S Murri; S Zientara; B Durand; J P Durand; H Zeller
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

5.  Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis.

Authors:  Robert B Tesh; Amelia P A Travassos da Rosa; Hilda Guzman; Tais P Araujo; Shu-Yuan Xiao
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

6.  Experimental infection of horses with West Nile virus.

Authors:  Michel L Bunning; Richard A Bowen; C Bruce Cropp; Kevin G Sullivan; Brent S Davis; Nicholas Komar; Marvin S Godsey; Dale Baker; Danielle L Hettler; Derek A Holmes; Brad J Biggerstaff; Carl J Mitchell
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

7.  Isolation of two strains of West Nile virus during an outbreak in southern Russia, 1999.

Authors:  D K Lvov; A M Butenko; V L Gromashevsky; V P Larichev; S Y Gaidamovich; O I Vyshemirsky; A N Zhukov; V V Lazorenko; V N Salko; A I Kovtunov; K M Galimzyanov; A E Platonov; T N Morozova; N V Khutoretskaya; E O Shishkina; T M Skvortsova
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883

8.  Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000.

Authors:  D Weiss; D Carr; J Kellachan; C Tan; M Phillips; E Bresnitz; M Layton
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

9.  Clinical characteristics of the West Nile fever outbreak, Israel, 2000.

Authors:  M Y Chowers; R Lang; F Nassar; D Ben-David; M Giladi; E Rubinshtein; A Itzhaki; J Mishal; Y Siegman-Igra; R Kitzes; N Pick; Z Landau; D Wolf; H Bin; E Mendelson; S D Pitlik; M Weinberger
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

10.  Serologic evidence of West Nile virus transmission, Jamaica, West Indies.

Authors:  Alan P Dupuis; Peter P Marra; Laura D Kramer
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

View more
  111 in total

Review 1.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.

Authors:  David C Clark; Aaron C Brault; Elizabeth Hunsperger
Journal:  Arch Virol       Date:  2012-05-17       Impact factor: 2.574

Review 2.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

3.  Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters.

Authors:  Marina T Siirin; Amelia P A Travassos da Rosa; Patrick Newman; Carolyn Weeks-Levy; Beth-Ann Coller; Shu-Yuan Xiao; Michael M Lieberman; Douglas M Watts
Journal:  Am J Trop Med Hyg       Date:  2008-12       Impact factor: 2.345

Review 4.  West Nile virus: A re-emerging pathogen revisited.

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2012-04-12

5.  Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.

Authors:  Serafeim C Chaintoutis; Nikolaos Diakakis; Maria Papanastassopoulou; Georgios Banos; Chrysostomos I Dovas
Journal:  Clin Vaccine Immunol       Date:  2015-07-15

6.  Molecular Identification and Phylogenetic Analysis of Acetylcholinesterase-2 Gene From Culex pipiens And Culex quinquefasciatus (Diptera: Culicine) in Nigeria.

Authors:  A B Onoja; M M Maina; A V Opayele
Journal:  Niger Vet J       Date:  2018-12-13

7.  West nile virus: characteristics of an african virus adapting to the third millennium world.

Authors:  Marina Monini; Emiliana Falcone; Luca Busani; Roberto Romi; Franco Maria Ruggeri
Journal:  Open Virol J       Date:  2010-04-22

8.  Seroconversion in wild birds and local circulation of West Nile virus, Spain.

Authors:  Jordi Figuerola; Ramon Soriguer; Gema Rojo; Concepción Gómez Tejedor; Miguel Angel Jimenez-Clavero
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

9.  A metapopulation model to simulate West Nile virus circulation in Western Africa, Southern Europe and the Mediterranean basin.

Authors:  Benoit Durand; Gilles Balança; Thierry Baldet; Véronique Chevalier
Journal:  Vet Res       Date:  2010-01-18       Impact factor: 3.683

10.  West Nile virus antibodies in wild birds, Morocco, 2008.

Authors:  Jordi Figuerola; Riad E Baouab; Ramon Soriguer; Ouafaa Fassi-Fihri; Francisco Llorente; Miguel Angel Jímenez-Clavero
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.